Nichols, Russell M. http://orcid.org/0000-0001-7771-7366
Macpherson, Lisa
Patel, Dipak R.
Yeh, Wendy W.
Peppercorn, Amanda
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial
https://doi.org/10.1007/s40121-024-00918-1
Funding for this research was provided by:
Eli Lilly and Company
GSK
Vir
Article History
Received: 23 October 2023
Accepted: 9 January 2024
First Online: 30 January 2024
Declarations
:
: Russell M. Nichols, Lisa Macpherson, and Dipak Patel are employees and shareholders of Eli Lilly and Company. Wendy W. Yeh is an employee and shareholder of Vir Biotechnology. Amanda Peppercorn is an employee and shareholder of GSK.
: The study received approval from the relevant ethics committee(s) and was conducted in accordance with the Declaration of Helsinki of 1964. Detailed information about the ethical review board is provided as supplemental information. All patients provided written informed consent for study participation.